CEACAM8 and osteonecrosis: Taken together, our results indicate that with BPs and pre-existing periapical disease, ABX treatment induces osteonecrosis formation and osteoclasts number, but does not significantly affect the number of CD66b+ granulocytes and CD3+ T-cells (Fig. 6e).